Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT04277598` - A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer	Phase 1/Phase 2
Terminated	`NCT05438251` - Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)	Phase 4
Completed	`NCT01912092` - Askina Calgitrol Paste Diabetic Foot Ulcers	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT04277598 - A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

Phase 1/Phase 2

Terminated

NCT05438251 - Exploring the Effect of Fespixon Cream for the Treatment of Diabetic Foot Ulcers (TEXAS 3A, 3B)

Phase 4

Completed

NCT01912092 - Askina Calgitrol Paste Diabetic Foot Ulcers

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04372355
Study type	Interventional
Source	Srinakharinwirot University
Contact
Status	Completed
Phase	Phase 2
Start date	June 19, 2019
Completion date	June 19, 2020

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms